Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients

Last updated: May 12, 2025
Sponsor: Stony Brook University
Overall Status: Completed

Phase

1

Condition

Mucositis

Treatment

Control

Hydrogen tablets

Clinical Study ID

NCT05278260
SBU-HYDROGEN-HN-RT
  • Ages > 18
  • All Genders

Study Summary

This study explores the effects of hydrogen-rich water on alleviating the radiation-induced acute mucositis in head and neck cancer patients

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of a biopsy proven head and neck cancer, early or advanced stage, primaryor recurrent tumor,

  • Planning to receive daily fractionated radiotherapy for over 4 weeks' duration

  • Karnofsky Performance Score (KPS) of at least 70

  • Able to describe pain

  • Able to swallow food and water

  • Able to sign consent

Exclusion

Exclusion Criteria:

Study Design

Total Participants: 24
Treatment Group(s): 2
Primary Treatment: Control
Phase: 1
Study Start date:
May 25, 2022
Estimated Completion Date:
November 13, 2024

Connect with a study center

  • Stony Brook Cancer Center

    Stony Brook, New York 11794
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.